功能性胃肠病多学科与标准消化内科医师治疗的长期结局:一项随机试验
这项单中心实用性试验将188例符合罗马IV标准的功能性胃肠病患者按1:2随机分配至消化内科医师标准治疗组或多学科门诊组,在治疗结束后12个月评估结局。改良意向性分析纳入143例(标准组46例,多学科组97例),多学科组在症状总体改善「5/5好很多」、肠易激综合征严重程度评分降低≥50分及生活质量方面优于标准组,增量成本效果比为每增加3555澳元获得一个质量调整生命年。
要点
- 治疗结束12个月后,多学科组37% vs 标准组20%的患者评价症状「5/5好很多」(P = .04)。
- 肠易激综合征患者中,多学科组66% vs 标准组38%达到严重程度评分降低≥50分(P = .02)。
- 生活质量评分标准组0.75 vs 多学科组0.77(P = .03),标准组更低。
核心结论
- 治疗结束12个月后,与仅由消化内科医师提供的标准治疗相比,整合多学科临床治疗在症状改善、心理状态、生活质量和成本方面获得改善的患者比例更高。
研究设计与样本
- 单中心实用性试验,将符合罗马IV标准的功能性胃肠病患者按1:2随机分配至消化内科医师标准治疗组或多学科门诊组(由消化内科医师、营养师、肠道催眠治疗师、精神科医师和生物反馈物理治疗师组成)。
- 共随机188例患者,143例(标准组46例,多学科组97例)纳入长期改良意向性分析,结局在治疗结束后12个月评估。
主要发现
- 治疗结束12个月后达到总体症状改善的患者比例:标准组65%(30/46) vs 多学科组76%(74/97)(P = .17),未达统计学显著。
- 将症状评价为「5/5好很多」的患者比例:标准组20%(9/46) vs 多学科组37%(36/97)(P = .04)。
- 肠易激综合征患者中肠易激综合征严重程度评分降低≥50分的比例:标准组38% vs 多学科组66%(P = .02)。
- 焦虑和抑郁评分标准组12 vs 多学科组10(P = .19),生活质量评分标准组0.75 vs 多学科组0.77(P = .03),标准组更低。
- 增量成本效果比显示,多学科门诊每多花费3555澳元,可多获得一个质量调整生命年。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Functional gastrointestinal disorders are common and costly to the healthcare system. In the Multidisciplinary Treatment of Functional Gastrointestinal Disorders study, we demonstrated that multidisciplinary care resulted in superior clinical and cost outcomes, when compared with standard gastroenterologist-only care at end of treatment. In this study we evaluate the longer-term outcomes. METHODS: In a single-center, pragmatic trial patients with Rome IV criteria-defined functional gastrointestinal disorders were randomized 1:2 to a gastroenterologist-only standard care vs a multidisciplinary clinic comprising gastroenterologists, dietitians, gut hypnotherapists, psychiatrists, and biofeedback physiotherapists. Outcomes in this study were assessed 12 months after the end of treatment. Global symptom improvement was assessed by using a 5-point Likert scale. Symptoms, specific disorder status, psychological state, quality of life, and cost were additional outcomes. A modified intention-to-treat analysis was performed. RESULTS: Of 188 randomized patients, 143 (46 standard care, 97 multidisciplinary) formed the longer-term modified intention-to-treat analysis. Sixty-two percent of multidisciplinary clinic patients saw allied clinicians. Sixty-five percent (30/46) standard care versus 76% (74/97) multidisciplinary clinic patients achieved global symptom improvement 12 months after end of treatment (P = .17), whereas 20% (9/46) versus 37% (36/97) rated their symptoms as "5/5 much better" (P = .04). A ≥50-point reduction in Irritable Bowel Syndrome Severity Scoring System occurred in 38% versus 66% (P = .02), respectively, for irritable bowel syndrome patients. Anxiety and depression were greater in the standard care than multidisciplinary clinic (12 vs 10, P = .19), and quality of life was lower in standard care than the multidisciplinary clinic (0.75 vs 0.77, P =·.03). An incremental cost-effectivness ratio found that for every additional 3555AUD spent in the multidisciplinary clinic, a further quality-adjusted life year was gained. CONCLUSIONS: Twelve months after the completion of treatment, integrated multidisciplinary clinical care achieved a greater proportion of patients with improvement of symptoms, psychological state, quality of life, and cost, compared with gastroenterologist-only care. CLINICAL TRIALS: gov: number NCT03078634.
引用
- Basnayake C, Kamm MA, Stanley A, et al. Long-Term Outcome of Multidisciplinary Versus Standard Gastroenterologist Care for Functional Gastrointestinal Disorders: A Randomized Trial. Clin Gastroenterol Hepatol. 2021. PMID: 34896645. doi:10.1016/j.cgh.2021.12.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。